SAN FRANCISCO, CA--(Marketwire - June 08, 2008) - A major long-term U.S. clinical trial to study whether intense control of blood glucose in type 2 diabetes would reduce the risk of cardiovascular disease found a reduction in cardiovascular events, but it was not statistically significant, according to a report presented here today at the American Diabetes Association’s 68th Annual Scientific Sessions.
